IFNL3 and infection: Contrary to the results of Lampertico et al., a number of other analyses have not found a significant relationship between IFNL3 genotype and response to PegIFN alfa in patients with HBeAg-negative CHB [17, 21], including a number of southern European cohorts, most of whom had HBV genotype D infection [20, 23, 31].